Skip to main content
. 2022 Oct 20;16:1031075. doi: 10.3389/fnins.2022.1031075

FIGURE 1.

FIGURE 1

Utilization of different model systems and approaches in neurodevelopmental research. (A) Modeling of NDDs using in vivo and in vitro model systems. (B) Human-specific iPSC model systems are used for NDD characterization, drug screening and stem cell-based therapies, whereas animal models and human-specific COs can be used for NDD characterization and drug screening, aiming to improve patients’ quality of life. ASD, Autism Spectrum Disorder; PH, Periventricular Heterotopia; iPSCs, induced pluripotent stem cells; NPCs, neural progenitor cells; NDD, Neurodevelopmental disorder.